BioLife Solutions (BLFS) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $35.25 -0.79%
Revenue Growth %: +3.3%
Financial Fact:
Research and development: 496.87K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +3.3%
Financial Fact:
Research and development: 496.87K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q1 EPS of ($0.10), $0.02 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $1.85 million versus the consensus estimate of $2.2 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Lynx Equity sees Micron and SanDisk breakout as volatility normalizes
- Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
